Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : sciclone pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Vincent Vega who wrote (440)	3/3/2000 12:43:00 AM
From: Skywatcher	Read Replies (1) \| Respond to of 1137

I have every confidence that every move is a strong move upward and that the future of this company and the key ingredient ZADAXIN are going to be extremely profitable. And combined with the BIOmania (long overdue for the good companies) we are ready for liftoff. And this is completely discounting the other drugs and treatments that they are working on...the Cystic Fibrosis, the STEM cell research, the CANCER implications of Zadaxin, and the new tuberculosis research. chris